The Discovery Series from Oxford Global brings together experts and scientist from european pharmaceutical organizations as well as biotech companies and research institutions to exchange about the future of drug discovery and development.

NovAliX participants:

David Moreno Delgado, Biology team leader

David will participate in the roundtable discussion on the subject: “Developing a successful NCE drug discovery program- assay development of biochemical, cellular and phenotypic screening strategies”

Lutz Paessens, Business development manager

Lutz will be available during the event to answer to any question about our services offer.

This website uses cookies to improve user experience